NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Appendix 4E and 2025 full year accounts

Date and time
Announcement type
Financial Results

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV